Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Holding(s) in Company

17 Oct 2024 07:00

RNS Number : 5083I
IXICO plc
17 October 2024
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Ixico plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Gresham House Asset Management Ltd

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

 

 

City and country of registered office (if applicable)

London, UK

5. Date on which the threshold was crossed or reachedvi:

11/10/2024

6. Date on which issuer notified (DD/MM/YYYY):

16/10/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.70%

N/A

10.70%

5,357,100

Position of previous notification (if

applicable)

11.46%

11.46%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BFXR4C20

5,357,100

10.70%

SUBTOTAL 8. A

5,357,100

10.70%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Gresham House Asset Management Limited

10.70%

10.70%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Gresham House Asset Management Ltd

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

Gresham House Asset Management Ltd

Date of completion

16/10/2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLMFBMTMTJBTTI
Date   Source Headline
24th Jan 20252:16 pmRNSResult of AGM
16th Dec 20247:00 amRNS-RCommercial agreement with PETNET Solutions Inc
10th Dec 20247:00 amRNSContract Win
4th Dec 202411:35 amRNSShare Option Award & PDMR Dealings
4th Dec 20247:00 amRNSFinancial Results for year ended 30 September 2024
25th Nov 20247:00 amRNSNotice of Results and Investor Presentation
31st Oct 20247:00 amRNSShare Option Awards & PDMR Dealing
30th Oct 20244:50 pmRNSHolding(s) in Company
29th Oct 20244:00 pmRNSHolding(s) in Company
29th Oct 202410:58 amRNSHolding(s) in Company
28th Oct 20244:59 pmRNSHolding(s) in Company
28th Oct 202411:00 amRNSDirector/PDMR Shareholdings
25th Oct 202412:55 pmRNSResult of GM, Issue of Equity & TVR
22nd Oct 20243:00 pmRNSCorrection of clerical error
17th Oct 20247:00 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSResult of Retail Offer
10th Oct 20241:30 pmRNSExercise of Options & Director/PDMR Purchase
9th Oct 20247:00 amRNSResult of Placing and Subscription
8th Oct 20244:40 pmRNSRetail Offer
8th Oct 20244:35 pmRNSPlacing and Subscription
14th Aug 20247:01 amRNSTrading Update
14th Aug 20247:00 amRNSContract Win
5th Aug 20247:00 amRNSBoard Appointment
29th Jul 20247:00 amRNSFurther progress in HD consortium
20th Jun 20245:45 pmRNSHolding(s) in Company
19th Jun 20247:00 amRNSContract Win
23rd May 20247:00 amRNSContract Win
21st May 20247:00 amRNSHalf-year Report
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.